Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Drug Metab Dispos ; 37(5): 1009-16, 2009 May.
Article in English | MEDLINE | ID: mdl-19220985

ABSTRACT

Carnitine/organic cation transporter (OCTN) 2 (SLC22A5) plays a pivotal role in renal tubular reabsorption of carnitine, a vitamin-like compound, on apical membranes of proximal tubules, but its role in relation to therapeutic drugs remains to be clarified. The purpose of the present study was to elucidate the involvement of OCTN2 in renal disposition of a beta-lactam antibiotic, cephaloridine (CER), based on experiments with juvenile visceral steatosis (jvs) mice, which have a functional deficiency of the octn2 gene. Renal clearance of CER during constant intravenous infusion in wild-type mice was much higher than could be accounted for by glomerular filtration, but was decreased by increasing the infusion rate with minimal change in kidney-to-plasma concentration ratio, suggesting the existence of saturable transport mechanism(s) across the apical membranes. The plasma concentration profile and kidney-to-plasma concentration ratio after intravenous injection in jvs mice were higher than those in wild-type mice, whereas renal clearance in jvs mice was much lower than that in wild-type mice and could be accounted for by glomerular filtration. Uptake of CER by mouse OCTN2 was shown in Xenopus laevis oocytes expressing mouse OCTN2. The CER transport by OCTN2 exhibited saturation with K(m) of approximately 3 mM, which is similar to the renal CER concentration exhibiting saturation in renal clearance in vivo. The OCTN2-mediated CER transport was inhibited by carnitine and independent of Na(+) replacement in the medium. These results show OCTN2 on apical membranes of proximal tubules plays a major role in renal secretion of CER in mice.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Cephaloridine/pharmacokinetics , Kidney/metabolism , Organic Cation Transport Proteins/genetics , Organic Cation Transport Proteins/metabolism , Animals , Blood Proteins/metabolism , Carnitine/pharmacology , Chromatography, High Pressure Liquid , Glomerular Filtration Rate , Male , Membranes/metabolism , Mice , Mice, Inbred C3H , Mice, Knockout , Oocytes/metabolism , Organic Cation Transport Proteins/antagonists & inhibitors , Protein Binding , RNA, Complementary/biosynthesis , RNA, Complementary/genetics , Solute Carrier Family 22 Member 5 , Transfection , Xenopus laevis
2.
Biomed Chromatogr ; 15(2): 79-82, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11268046

ABSTRACT

A technique involving rapid sampling of cephaloridine in rat blood was achieved using a combination of microdialysis and sensitive microbore liquid chromatography. A microdialysis probe was inserted into the jugular vein/right atrium of a Sprague-Dawley rat. Then after a real-time collection of the analyte by microdialysis, the dialysate was automatically injected into a liquid chromatographic system via an on-line injector. Following a 2 h stabilization period after the surgical procedure, cephaloridine (20 mg/kg, i.v.) was then administered via the femoral vein. Isocratic elution of cephaloridine was carried out with a mobile phase containing methanol-20 mM monosodium phosphate (25:75, v/v, pH 5.5), and the flow rate of the mobile phase was 0.05 mL/min within 10 min. Intra- and inter-assay accuracy and precision of the assay were each less than 10%. The in vivo recovery of the cephaloridine from the microdialysate was 49.7 +/- 8.0% and 42.4 +/- 8.4% for 0.5 and 1 microg/mL standards (n = 6), respectively. Based on the pharmacokinetic analysis, the elimination half-life was 32.2 +/- 8.6 min by cephaloridine administration (20 mg/kg, i.v., n = 6).


Subject(s)
Cephaloridine/blood , Cephalosporins/blood , Chromatography, Liquid/methods , Animals , Cephaloridine/pharmacokinetics , Cephalosporins/pharmacokinetics , Male , Microdialysis , Rats , Rats, Sprague-Dawley , Reproducibility of Results
3.
Biochemistry ; 39(38): 11777-87, 2000 Sep 26.
Article in English | MEDLINE | ID: mdl-10995246

ABSTRACT

Lipopolysaccharide (LPS), the primary lipid on the surface of Gram-negative bacteria, is thought to act as a permeability barrier, making the outer membrane relatively impermeable to hydrophobic antibiotics, detergents, and host proteins. Mutations in the LPS biosynthetic apparatus increase bacterial susceptibility to such agents. To determine how this increased susceptibility is mediated, we have correlated antibiotic susceptibilities of rough (antibiotic resistant) and deep rough (antibiotic susceptible) bacterial strains with antibiotic permeabilities and fluorescent probe binding kinetics for bilayers composed of LPS purified from the same strains. Bilayer permeabilities of two hydrophobic beta-lactam antibiotics were measured by encapsulating the appropriate beta-lactamases in large unilamellar vesicles. In the presence of MgCl(2), permeabilities of LPS bilayers from rough and deep rough bacteria were similar and significantly lower than those of bacterial phospholipids (BPL). Addition of BPL to the LPS bilayers increased their antibiotic permeability to approximately the level of the BPL bilayers. Binding rates of the fluorescent probe bis-aminonaphthylsulfonic acid (BANS) were 2 orders of magnitude slower for both rough and deep rough LPS bilayers compared to that of bilayers composed of BPL or mixtures of LPS and BPL. On the basis of these results and the observation that deep rough bacteria have higher levels of phospholipid on their surface than do rough bacteria (Kamio, Y., and Nikaido, H. (1976) Biochemistry 15, 2561-2569), we argue that the high susceptibility of deep rough bacteria is due to the presence of phospholipids on their surface. Experiments with phospholipid bilayers showed that the addition of PEG-lipids (containing covalently attached hydrophilic polymers) had little effect on permeability and binding rates, whereas the addition of cholesterol reduced permeability and slowed binding to levels approaching those of LPS. Therefore, we argue that the barrier provided by LPS is primarily due to its tight hydrocarbon chain packing (Snyder et al., (1999) Biochemistry 38, 10758-10767) rather than to its polysaccharide headgroup.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Cell Membrane Permeability , Escherichia coli/metabolism , Fluorescent Dyes/pharmacokinetics , Lipopolysaccharides/pharmacokinetics , Salmonella typhimurium/metabolism , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Binding Sites , Cell Membrane Permeability/drug effects , Cephaloridine/pharmacokinetics , Cephaloridine/pharmacology , Cephalosporins/pharmacokinetics , Cephalosporins/pharmacology , Cholesterol/pharmacokinetics , Escherichia coli/drug effects , Escherichia coli/growth & development , Fluorescent Dyes/chemistry , Lipid Bilayers/pharmacokinetics , Lipopolysaccharides/chemistry , Microbial Sensitivity Tests , Phosphatidylcholines/pharmacokinetics , Phospholipids/pharmacokinetics , Rhodamines/pharmacokinetics , Salmonella typhimurium/drug effects , Salmonella typhimurium/growth & development , Sulfones/pharmacokinetics , X-Ray Diffraction , beta-Lactam Resistance
4.
J Biol Chem ; 275(3): 1699-707, 2000 Jan 21.
Article in English | MEDLINE | ID: mdl-10636865

ABSTRACT

Therapeutic use of cephaloridine, a beta-lactam antibiotic, in humans is associated with carnitine deficiency. A potential mechanism for the development of carnitine deficiency is competition between cephaloridine and carnitine for the renal reabsorptive process. OCTN2 is an organic cation/carnitine transporter that is responsible for Na(+)-coupled transport of carnitine in the kidney and other tissues. We investigated the interaction of several beta-lactam antibiotics with OCTN2 using human cell lines that express the transporter constitutively as well as using cloned human and rat OCTN2s expressed heterologously in human cell lines. The beta-lactam antibiotics cephaloridine, cefoselis, cefepime, and cefluprenam were found to inhibit OCTN2-mediated carnitine transport. These antibiotics possess a quaternary nitrogen as does carnitine. Several other beta-lactam antibiotics that do not possess this structural feature did not interact with OCTN2. The interaction of cephaloridine with OCTN2 is competitive with respect to carnitine. Interestingly, many of the beta-lactam antibiotics that were not recognized by OCTN2 were good substrates for the H(+)-coupled peptide transporters PEPT1 and PEPT2. In contrast, cephaloridine, cefoselis, cefepime, and cefluprenam, which were recognized by OCTN2, did not interact with PEPT1 and PEPT2. The interaction of cephaloridine with OCTN2 was Na(+)-dependent, whereas the interaction of cefoselis and cefepime with OCTN2 was largely Na(+)-independent. Furthermore, the Na(+)-dependent, OCTN2-mediated cellular uptake of cephaloridine could be demonstrated by direct uptake measurements. These studies show that OCTN2 plays a crucial role in the pharmacokinetics and therapeutic efficacy of certain beta-lactam antibiotics such as cephaloridine and that cephaloridine-induced carnitine deficiency is likely to be due to inhibition of carnitine reabsorption in the kidney.


Subject(s)
Anti-Bacterial Agents/metabolism , Carnitine/pharmacokinetics , Carrier Proteins/metabolism , Membrane Proteins/metabolism , Organic Cation Transport Proteins , Acetylcarnitine/pharmacokinetics , Animals , Carnitine/analogs & derivatives , Carnitine/antagonists & inhibitors , Cefadroxil/pharmacology , Cefepime , Cephaloridine/pharmacokinetics , Cephalosporins/chemistry , Cephalosporins/pharmacokinetics , Dose-Response Relationship, Drug , HeLa Cells , Humans , Kinetics , Nitrogen/metabolism , Rats , Sodium/metabolism , Solute Carrier Family 22 Member 5 , Tumor Cells, Cultured
5.
Kidney Int ; 56(6): 2128-36, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10594788

ABSTRACT

UNLABELLED: Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity. BACKGROUND: Cephaloridine (CER) has been used to elucidate the mechanisms of cephalosporin antibiotic-induced nephrotoxicity. Organic anion transporters have been thought to mediate CER uptake by the proximal tubule. The purpose of this study was to elucidate the possible involvement of organic anion transporter 1 (OAT1) in CER-induced nephrotoxicity. METHODS: A mouse terminal proximal straight tubule (S3) cell line stably expressing rat OAT1 (S3 rOAT1) was established and used in this study. The cellular uptake of [14C]-para-aminohippuric acid (PAH), a prototype organic anion, and that of [14C]-CER were measured. The effects of CER on the viability of the cells and the amount of lipid peroxidation were estimated. RESULTS: S3 rOAT1 expressed a functional organic anion transporter in the cytoplasmic membrane, and exhibited CER uptake activity. CER treatment resulted in a more significant decrease in the viability and a more significant increase in the amount of lipid peroxidation in S3 rOAT1 than in S3 cells transfected with an expression vector lacking the rOAT1 insert. Probenecid, an inhibitor of organic anion transport, and probucol, an antioxidant, significantly suppressed the decrease in viability and increase in the amount of lipid peroxidation in S3 rOAT1 treated with CER. The effects of various cephalosporin antibiotics on the uptake of [14C]PAH were correlated significantly with the effects of these drugs on cell viability. CONCLUSIONS: These results suggest that rOAT1 is, at least in part, responsible for the cellular uptake of CER and therefore CER-induced nephrotoxicity.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Cephaloridine/toxicity , Cephalosporins/toxicity , Kidney Diseases/chemically induced , Kidney Tubules, Proximal/pathology , Animals , Anion Transport Proteins , Anticholesteremic Agents/pharmacology , Antigens, Polyomavirus Transforming/genetics , Biological Transport/genetics , Carbon Radioisotopes , Cell Line , Cell Survival/drug effects , Cephaloridine/pharmacokinetics , Cephalosporins/pharmacokinetics , DNA, Complementary , Kidney Tubules, Proximal/chemistry , Kidney Tubules, Proximal/metabolism , Lipid Peroxidation/drug effects , Mice , Mice, Transgenic , Mutagenesis/physiology , Probenecid/pharmacology , Probucol/pharmacology , Uricosuric Agents/pharmacology , p-Aminohippuric Acid/pharmacokinetics
6.
Fundam Appl Toxicol ; 38(2): 184-90, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9299192

ABSTRACT

Previous work has shown a reduction in cephaloridine nephrotoxicity in a diabetic rat model. The following studies examined in vitro cephaloridine toxicity in renal slices from normoglycemic and diabetic Fischer 344 rats. Diabetes was induced by acute intraperitoneal injection of 35 mg/kg streptozotocin. Renal cortical slices were isolated from normoglycemic and diabetic animals. Tissues were exposed to 0-5 mM cephaloridine for 15-120 min. Pyruvate-directed gluconeogenesis was diminished in all groups exposed to 2-5 mM cephaloridine for 60-120 min. Leakage of lactate dehydrogenase (LDH) was apparent only in the normoglycemic group in the presence of 4-5 mM cephaloridine for 120 min. LDH leakage was not increased at any cephaloridine concentration in the diabetic tissue. Total glutathione levels were compared in renal cortical slices exposed to cephaloridine for 30-120 min. Baseline values for glutathione were comparable between normoglycemic and diabetic tissue suggesting that the mechanism for reduced toxicity was not due to higher glutathione levels in diabetic tissue. Total glutathione levels were diminished more rapidly in normoglycemic than diabetic tissue by incubation with 5 mM cephaloridine. Comparison of cephaloridine accumulation indicated that diabetic tissue accumulated less cephaloridine than the normoglycemic group when tissues were incubated with 0-2 mM cephaloridine. However, renal slice accumulation was similar between normoglycemic and diabetic groups following in vitro incubation with 4-5 mM cephaloridine. These results suggest that the mechanism for reduced in vitro cephaloridine toxicity in diabetic tissue cannot be limited to differences in accumulation and must include an unidentified cellular component.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/toxicity , Cephaloridine/pharmacokinetics , Cephaloridine/toxicity , Diabetes Mellitus, Experimental/pathology , Kidney/pathology , Animals , Glomerular Filtration Rate/drug effects , Gluconeogenesis/drug effects , Glutathione/metabolism , In Vitro Techniques , Kidney/metabolism , L-Lactate Dehydrogenase/metabolism , Male , Rats , Rats, Inbred F344 , Renal Circulation/drug effects
7.
Antimicrob Agents Chemother ; 41(8): 1721-4, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9257748

ABSTRACT

Beta-lactam resistance in mycobacteria results from an interplay between the following: (i) beta-lactamase production, (ii) affinity of the penicillin-binding proteins (PBPs) for the drugs, and (iii) permeation of the drugs. A laboratory mutant of Mycobacterium smegmatis was studied in order to evaluate the roles of these factors in beta-lactam resistance. Mutant M13 was between 7- and 78-fold more resistant than the wild type to cephaloridine, cefoxitin, cefazolin, cefamandole, and cephalothin. Increased beta-lactamase activity toward these antibiotics was not observed in the mutant. The PBP profiles of the wild type and M13 were comparable. However, the affinities of PBP 1 for the beta-lactams tested were lower for the mutant than for the wild type. The permeation of the drugs measured in intact cells was lower for M13 than for the parent strain. The liposome swelling technique, which could be used for cephaloridine, also supported this view. Reduced permeation was not restricted to the beta-lactams alone. Glycine uptake was also lower in M13. Taken together, the results suggest that decreased affinities of PBP 1 for beta-lactams, combined with the decreased permeability of the cell wall of the mutant, lead to the development of high-level acquired beta-lactam resistance.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Bacterial Proteins , Cell Membrane Permeability , Hexosyltransferases , Mycobacterium/metabolism , Peptidyl Transferases , beta-Lactam Resistance/physiology , Carrier Proteins/drug effects , Cefamandole/pharmacokinetics , Cefazolin/pharmacokinetics , Cell Membrane Permeability/drug effects , Cephaloridine/pharmacokinetics , Glycine/pharmacokinetics , Microbial Sensitivity Tests , Muramoylpentapeptide Carboxypeptidase/drug effects , Mycobacterium/drug effects , Penicillin-Binding Proteins
8.
Toxicology ; 108(1-2): 93-9, 1996 Apr 15.
Article in English | MEDLINE | ID: mdl-8644123

ABSTRACT

The renal toxicity of cephaloridine is reduced in a streptozotocin diabetic rat model. This study tested the hypothesis that renal cortical cephaloridine accumulation was diminished in diabetic rats. The following studies also investigated whether renal excretion was enhanced in diabetic rats. Male Fischer 344 rats were randomly divided into normoglycemic or diabetic groups. Diabetes was induced by injection (intraperitoneal, i.p.) of 35 mg/kg streptozotocin. Normoglycemic and diabetic rats were injected (i.p.) with 1500 mg/kg cephaloridine. Peak plasma cephaloridine levels were similar in both groups. Renal cortical accumulation was diminished (P < 0.05) in the diabetic group 1 and 4 h after cephaloridine injection. Urinary cephaloridine excretion was enhanced (P < 0.05) in the diabetic group relative to the normoglycemic animals during the first 4 h after cephaloridine injection. Comparisons between normoglycemic and diabetic groups indicated renal cortical cephaloridine accumulation was lower in the diabetic group. These findings would support the hypothesis that reduced cephaloridine toxicity in diabetic animals was due to reduced renal cortical accumulation of the toxin. These data also demonstrate that cephaloridine excretion was enhanced in the diabetic group and may contribute to the diminished renal accumulation.


Subject(s)
Cephaloridine/pharmacokinetics , Cephalosporins/pharmacokinetics , Diabetes Mellitus, Experimental/metabolism , Kidney/metabolism , Animals , Cephaloridine/toxicity , Cephaloridine/urine , Cephalosporins/toxicity , Cephalosporins/urine , Kidney/drug effects , Male , Rats , Rats, Inbred F344
9.
J Antimicrob Chemother ; 37(2): 341-4, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8707744

ABSTRACT

The permeability to cephaloridine was studied in five Haemophilus influenzae strains (four non-typable and one type b) using the Zimmermann and Rosselet method. The beta-lactamase activity was due to a plasmid-encoded TEM-1 enzyme. High permeability coefficients were measured in all strains examined. No great differences in permeability coefficients were found, even between strains with marked differences in OMP electrophoretic profiles.


Subject(s)
Cephaloridine/pharmacokinetics , Haemophilus influenzae/metabolism , Bacterial Typing Techniques , Haemophilus influenzae/classification , Haemophilus influenzae/ultrastructure , Membranes/metabolism , Microbial Sensitivity Tests , Permeability , Species Specificity , beta-Lactamases/metabolism
10.
Biochem Pharmacol ; 50(4): 562-4, 1995 Aug 08.
Article in English | MEDLINE | ID: mdl-7646563

ABSTRACT

It has been demonstrated recently that cephaloridine (Cld) inhibits the tubular reabsorption of filtered carnitine (Carn) in the rabbit kidney. This interaction has suggested that the limited net cell-to-luminal fluid movement of Cld following its secretory transport across the antiluminal membrane might result from a balance of active Cld reabsorption by a Carn carrier at the brush border approximately equal to its secretion into the tubular fluid, rather than the previously proposed luminal membrane block. Studies were done to determine the effects of L-Carn, 750 mg/kg, i.v. on the tubular secretion and cortical concentrations of Cld, infused i.v. at a dose of 28 mg/kg (Carn:Cld molar ratio = 70:1). The fractional excretions of Cld during three consecutive periods of 10 min each, one before and two following the bolus infusion of Carn, were (means +/- SEM): 1.18 +/- 0.14, 1.20 +/- 0.14, and 1.16 +/- 0.11, respectively (N = 6 each; differences NS). Cortex-to-serum concentration ratios of Cld in control and Carn-treated rabbits were 10.43 +/- 0.32 and 10.16 +/- 0.86, respectively (NS). The data provide evidence against the reabsorptive transport of Cld by a Carn carrier, and do not support a model of balanced secretion and reabsorption as the cause of limited clearance despite significant secretory transport of Cld into the tubular cell.


Subject(s)
Carnitine/pharmacology , Cephaloridine/pharmacokinetics , Kidney Tubules/drug effects , Animals , Biological Transport, Active , Cephaloridine/blood , Cephaloridine/urine , Female , Inulin/pharmacokinetics , Kidney Cortex/metabolism , Kidney Tubules/metabolism , Rabbits
11.
J Chemother ; 6(6): 363-7, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7699421

ABSTRACT

The penetration rates of meropenem and imipenem through the outer membrane (OM) of Serratia marcescens was evaluated by the method of Zimmermann and Rosselet. To this aim, two strains of the specie were transformed with the pMON-01 plasmid DNA that carries the bla S gene from Xanthomonas maltophilia encoding for the L-1 beta-lactamase. The permeability of the transformants to cephaloridine was not affected by the presence of the plasmid. Imipenem was shown to penetrate the OM of the transformants at a rate 4- to 5-fold higher than that of meropenem and close to that of cephaloridine. Meropenem appeared more active than imipenem in inhibiting the targets as inferred from the calculated concentrations of antibiotic in the cell periplasm in the presence of MIC. The calculation of the target access index (TAI) indicated that a 20- to 50-fold decrease in permeability or increase in beta-lactamase activity would be required to significantly increase the MICs of imipenem or meropenem for these strains.


Subject(s)
Cell Membrane Permeability , Imipenem/pharmacokinetics , Serratia marcescens/metabolism , Thienamycins/pharmacokinetics , Cephaloridine/pharmacokinetics , DNA, Bacterial/genetics , Imipenem/pharmacology , Meropenem , Microbial Sensitivity Tests , Serratia marcescens/drug effects , Serratia marcescens/genetics , Thienamycins/pharmacology , Transformation, Bacterial , beta-Lactamases/genetics
12.
Antimicrob Agents Chemother ; 36(11): 2569-72, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1489208

ABSTRACT

Cefaclor sustained its inhibitory activity against a beta-lactamase-producing strain of Haemophilus influenzae. Although a relatively high permeability coefficient was calculated for ampicillin compared with that calculated for cefaclor, the resulting periplasmic concentration of cefaclor was 5.7 times that of ampicillin. The efficacy of cefaclor may be due to its higher beta-lactamase resistance, which allows it to achieve a greater periplasmic concentration and adequate binding to crucial penicillin-binding proteins.


Subject(s)
Bacterial Proteins , Cefaclor/pharmacology , Haemophilus influenzae/drug effects , Hexosyltransferases , Peptidyl Transferases , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/pharmacology , Binding, Competitive , Carrier Proteins/metabolism , Cefaclor/metabolism , Cefaclor/pharmacokinetics , Cell Membrane Permeability , Cephaloridine/pharmacokinetics , Cephalothin/pharmacokinetics , Haemophilus influenzae/metabolism , Iodine Radioisotopes , Kinetics , Muramoylpentapeptide Carboxypeptidase/metabolism , Penicillin V/metabolism , Penicillin-Binding Proteins , beta-Lactamases/metabolism
14.
Br Vet J ; 145(4): 389-93, 1989.
Article in English | MEDLINE | ID: mdl-2775988

ABSTRACT

The disposition kinetics and dosage regimen of cephaloridine were investigated in calves following a single intravenous dose of 10 mg.kg-1. The distribution half-life and elimination half-life were 0.16 +/- 0.02 and 1.96 +/- 0.16 h, respectively. The apparent volume of distribution was 0.64 +/- 0.06 l.kg-1 and total body clearance which represents the sum of all clearance processes, was 225.2 +/- 15.1 ml.kg-1.h-1. Based on kinetic parameters, a satisfactory intravenous dosage regimen of cephaloridine in calves would be 11.0 mg.kg-1 repeated every 8 h.


Subject(s)
Cattle/metabolism , Cephaloridine/pharmacokinetics , Animals , Cephaloridine/administration & dosage , Cephaloridine/analysis , Half-Life , Injections, Intravenous/veterinary , Male
15.
Chem Pharm Bull (Tokyo) ; 37(3): 785-90, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2752494

ABSTRACT

To elucidate the mechanism(s) of the relieving effect of saline on cephaloridine (CER) nephrotoxicity, rats were given CER in equal quantity (1 g/kg body weight; i.v.), but at two different concentrations (4 and 25%) in saline. Urinary excretion of glucose, which was investigated as an index for renal proximal tubular injury, revealed that the renal damage was less in the 4% CER 25 ml/kg group than in the 25% CER 4 ml/kg group. As to urinary excretions of CER, sodium, potassium and water, no significant differences were observed between the two groups in the first 2 h, but chloride in the 4% CER 25 ml/kg group showed higher values than in the 25% CER 4 ml/kg group. Plasma concentrations of sodium, potassium, chloride and CER, did not show any definite distinctions between the two groups. At the time-point of 20 min after the CER administration, renal CER content was significantly lower in the 4% CER 25 ml/kg group than in the 25% CER 4 ml/kg group. These results suggest that the sodium ion which is needed for cellular trapping of CER is competitively expended for cellular entry of the chloride ion in the kidney, and that the relieving effect of the saline on CER nephrotoxicity is ascribable to the loaded quantity of chloride ion.


Subject(s)
Cephaloridine/toxicity , Kidney Diseases/chemically induced , Sodium Chloride/therapeutic use , Animals , Cephaloridine/pharmacokinetics , Kidney Diseases/drug therapy , Male , Rats , Rats, Inbred Strains
16.
Vet Res Commun ; 13(4): 325-9, 1989.
Article in English | MEDLINE | ID: mdl-2781723

ABSTRACT

The disposition and dosage regimen of cephaloridine were investigated in healthy calves following a single intramuscular administration of 10 mg/kg. The absorption halflife, elimination halflife, apparent volume of distribution and total body clearance were 0.107 +/- 0.025 h, 2.08 +/- 0.14 h, 0.70 +/- 0.07 L kg-1 and 235.8 +/- 21.9 ml kg-1 h-1, respectively. Therapeutic plasma levels (greater than or equal to 1 micrograms/ml) were maintained for up to 7 h. A satisfactory intramuscular dosage regimen for cephaloridine in calves would be 10 mg/kg repeated at 8 h intervals.


Subject(s)
Cattle/metabolism , Cephaloridine/pharmacokinetics , Animals , Biological Availability , Cephaloridine/administration & dosage , Dose-Response Relationship, Drug , Injections, Intramuscular , Injections, Intravenous
17.
Antimicrob Agents Chemother ; 32(6): 912-8, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3415211

ABSTRACT

The protective effect of piperacillin against the nephrotoxicity of cephaloridine and gentamicin was examined in experimental animals. In rabbits, piperacillin was infused at a dose of 1 mg/kg (body weight) per min over 225 min and cephaloridine (300 mg/kg) was intravenously administered as a bolus 45 min after the start of a drip infusion. Blood urea nitrogen, serum creatinine, and N-acetyl-beta-D-glucosaminidase (NAG) in urine were measured as the renal toxicological parameters before and 24 h after cephaloridine dosing. Although the single administration of cephaloridine significantly elevated these parameters, the elevation was prevented by the concomitant administration of piperacillin. The protective effect of piperacillin was superior to those of cephalothin and fosfomycin. In rats, piperacillin (1,000 mg/kg) was intravenously administered and immediately followed by the intramuscular administration of gentamicin (100 mg/kg) every 24 h for 5 days. When piperacillin was concomitantly administered with gentamicin, the elevations of blood urea nitrogen, serum creatinine, and urinary NAG were significantly lower than when gentamicin was given alone. The concomitant administration of piperacillin resulted in a significant protective effect against the nephrotoxicity of cephaloridine in rabbits and of gentamicin in rats. Histopathological observation also supported the protective effect of piperacillin. The protective mechanism of piperacillin might be the inhibition of transport from the peritubular side to tubular cells for cephaloridine and from both the peritubular and luminal sides for gentamicin.


Subject(s)
Cephaloridine/toxicity , Gentamicins/toxicity , Kidney Diseases/prevention & control , Piperacillin/therapeutic use , Animals , Cephaloridine/blood , Cephaloridine/pharmacokinetics , Cephalothin/therapeutic use , Fosfomycin/therapeutic use , Gentamicins/blood , Gentamicins/pharmacokinetics , Kidney Cortex/metabolism , Kidney Cortex/pathology , Kidney Diseases/chemically induced , Kidney Diseases/metabolism , Kidney Medulla/metabolism , Kidney Medulla/pathology , Male , Rabbits , Rats , Rats, Inbred Strains
18.
Chemioterapia ; 7(2): 79-85, 1988 Apr.
Article in English | MEDLINE | ID: mdl-3293819

ABSTRACT

The bactericidal activity of cefuroxime, cephaloridine and cephalexin is evaluated in an in vitro model. The inocula are derived from an overnight static culture, or after a pre-incubation period of 1 or 2 hours to allow cell re-growth. The early bactericidal effect of the antibiotics is more evident using pre-incubated cells, especially for Staphylococcus aureus 663. At hour 8, with Escherichia coli 851/E, there is re-growth using the static inoculum, while the antibiotic effect is still evident using the pre-incubated one. The importance arises therefore for considering the phase of growth of the inoculum as a critical parameter when using in vitro models with varying concentrations of beta-lactam antibiotics.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Escherichia coli/drug effects , Staphylococcus aureus/drug effects , Cefuroxime/pharmacokinetics , Cephalexin/pharmacokinetics , Cephaloridine/pharmacokinetics , Escherichia coli/growth & development , Microbial Sensitivity Tests , Staphylococcus aureus/growth & development
19.
J Pharmacol Exp Ther ; 244(2): 520-5, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3346835

ABSTRACT

To examine the mechanisms of the nephrotoxic synergy of bacterial cell wall lipopolysaccharide (LPS) (or endotoxin) and the cephalosporin antibiotics, we have studied: 1) the effects on mean arterial blood pressure and the clearances of inulin, p-aminohippurate and cephaloridine (Cld) of a 12%-lethal dose of Escherichia coli 0111-B4 LPS (0.05 mg/kg b.wt.i.v.), with both low and high rates of saline infusion (0.1 ml/min vs. a 7.5-ml/kg load followed by 0.4 ml/min, respectively, in approximately 2-kg rabbits); 2) the separate and combined effects of LPS and saline infusion on the concentrations of Cld in renal cortex and serum; and 3) the separate and combined effects of LPS and saline infusion on the nephrotoxicity of Cld, quantified by acute tubular necrosis scoring and serum creatinine concentrations 48 hr after treatment with 90 mg/kg of Cld i.v. and by mitochondrial respiratory toxicity, depletion of reduced glutathione and production of lipid peroxidation products in renal cortex 1 hr after treatment with 90 to 360 mg/kg of Cld i.v. The following was found: 1) the increased saline infusion (saline) largely prevented an LPS-induced fall of inulin clearance and partially prevented a fall of blood pressure and p-aminohippurate and Cld clearance; 2) as a result, saline prevented slightly elevated late serum and cortical Cld concentrations in LPS-treated animals; 3) the tubular necrosis and elevation of serum creatinine caused by Cld alone was reduced slightly and that produced by the combination of LPS plus Cld was reduced greatly by saline; 4) the comparable mitochondrial respiratory toxicity found after Cld and LPS-plus-Cld was prevented by saline infusion.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cephaloridine/toxicity , Endotoxins/pharmacology , Kidney/drug effects , Lipopolysaccharides/toxicity , Sodium Chloride/pharmacology , Animals , Cephaloridine/pharmacokinetics , Drug Synergism , Female , Kidney/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Oxidation-Reduction , Rabbits
20.
Jpn J Ophthalmol ; 32(4): 392-400, 1988.
Article in English | MEDLINE | ID: mdl-3236562

ABSTRACT

The intraocular penetration of three current bactericidal broad-spectrum antibiotics, namely, gentamicin sulphate, sisomicin sulphate (Ensamycin) and cephaloridine, following subconjunctival injection was studied in 95 patients undergoing elective cataract surgery. Rapid and high penetration of all three drugs was evidenced by the fact that the first samples assayed by modified disc diffusion technique 15 minutes after injection showed drug levels effective against all susceptible pathogens. Peak levels of gentamicin, sisomicin and cephaloridine attained one hour after injection were 14.913 +/- 0.310, 19.000 +/- 0.408 and 30.830 +/- 1.195 micrograms/ml, respectively. Such high drug titres would provide drug concentrations 6 to 8 times the minimum inhibitory concentration necessary against susceptible organisms. The duration of the effective bioavailability of the drugs studied varied from 12 to 18 hours. We believe our study is the first to document the excellent penetration of sisomicin and the little-studied drug cephaloridine, and hope our results will open an avenue for in vivo studies to evaluate their clinical use.


Subject(s)
Aqueous Humor/metabolism , Cephaloridine/pharmacokinetics , Gentamicins/pharmacokinetics , Sisomicin/pharmacokinetics , Aged , Biological Availability , Cataract Extraction , Conjunctiva , Female , Humans , Injections , Male , Microbial Sensitivity Tests , Middle Aged , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...